Human Genome Sciences: revenue forecast 2011-2014
Shown is a revenue forecast for the biotech company Human Genome Sciences from 2011 to 2014.
Estimated revenue of biotech company Human Genome Sciences from 2011 to 2014 (in billion U.S. dollars)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Biotechnology in Spain
Global overview
6
- Premium Statistic Top global biotech companies - net sales 2023
- Premium Statistic Top global biotech companies based on number of employees 2024
- Premium Statistic Dedicated biotechnology company number comparison by select country 2022
- Basic Statistic Total number of biotechnology companies in Europe 2022
- Premium Statistic Biotechnology R&D expenditure in selected countries 2022
- Basic Statistic Biotechnology R&D intensity in enterprise sector by country 2022
Main figures
6
- Basic Statistic Production value of the Spanish biotech sector 2010-2020
- Basic Statistic Production value of the Spanish biotech sector in relation to GDP 2010-2020
- Premium Statistic Employees in internal R&D biotechnology activities Spain 2009-2020
- Premium Statistic Biotechnology researchers in internal R&D in Spain 2009-2020
- Premium Statistic Biotech facilities in Spain 2020, by region
- Premium Statistic Main problems for biotechnology development in Spain 2020
Companies
6
- Premium Statistic Companies performing biotechnology activities Spain in 2020, by relevance
- Premium Statistic Biotech enterprises in Spain 2020, by size
- Premium Statistic Biotech enterprises in Spain 2020, by region
- Premium Statistic Average turnover of biotech enterprises in Spain 2020, by region
- Premium Statistic Percentage distribution of turnover of biotech enterprises in Spain 2020, by region
- Premium Statistic Leading companies in R&D on biotechnology in Spain 2021
Areas of application
6
- Premium Statistic Patent applications from Spain to the EPO in 2021, by field of technology
- Premium Statistic Share of biotechnology companies in Spain 2020, by sector
- Premium Statistic Share of companies performing R&D biotech activities in Spain 2020, by field
- Premium Statistic Biotech projects on medicines in development in Spain 2023, by therapeutic area
- Premium Statistic Diagnostics and personalized medicine projects in Spain 2023, by therapeutic area
- Premium Statistic Biotech projects in development in Spain 2023, by therapeutic area
R&D investment
6
- Premium Statistic Internal investment in R&D activities in biotechnology in Spain 2009-2020
- Premium Statistic R&D spending on biotech activities made by companies in Spain 2009-2020
- Premium Statistic R&D spending on biotech activities made by the government in Spain 2009-2020
- Premium Statistic Biotechnology industry current expenses in Spain 2020, by nature of the expense
- Premium Statistic Biotechnology capital expenses in Spain 2020, by type
- Basic Statistic Biotechnology investment by origin of funds in Spain 2020
Funding
6
- Premium Statistic R&D intensity in the biotechnology business sector in Spain 2010-2021
- Premium Statistic R&D intensity in the biotech business sector as share of industry value added Spain
- Basic Statistic Private capital increases in Spanish biotech companies 2016-2021
- Basic Statistic Largest private capital increases of biotech companies in Spain 2021
- Basic Statistic Capital increases in publicly traded Spanish biotech companies 2016-2020
- Basic Statistic Capital increases in publicly traded biotech companies in Spain 2020, by company
Further related statistics
10
- Merck & Co total assets 2019-2023
- Merck & Co - expenditure on research and development 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co cash dividends declared 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- GSK's operating profit by division 2006-2021
- M&A capacities - changes for the global pharma industry 2008-2015
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2019-2023
- Merck & Co - expenditure on research and development 2006-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co cash dividends declared 2006-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- GSK's operating profit by division 2006-2021
- M&A capacities - changes for the global pharma industry 2008-2015
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Der Aktionär. (November 17, 2010). Estimated revenue of biotech company Human Genome Sciences from 2011 to 2014 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 31, 2024, from https://www.statista.com/statistics/270556/forecast-for-revenue-of-human-genome-sciences/
Der Aktionär. "Estimated revenue of biotech company Human Genome Sciences from 2011 to 2014 (in billion U.S. dollars)." Chart. November 17, 2010. Statista. Accessed December 31, 2024. https://www.statista.com/statistics/270556/forecast-for-revenue-of-human-genome-sciences/
Der Aktionär. (2010). Estimated revenue of biotech company Human Genome Sciences from 2011 to 2014 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 31, 2024. https://www.statista.com/statistics/270556/forecast-for-revenue-of-human-genome-sciences/
Der Aktionär. "Estimated Revenue of Biotech Company Human Genome Sciences from 2011 to 2014 (in Billion U.S. Dollars)." Statista, Statista Inc., 17 Nov 2010, https://www.statista.com/statistics/270556/forecast-for-revenue-of-human-genome-sciences/
Der Aktionär, Estimated revenue of biotech company Human Genome Sciences from 2011 to 2014 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/270556/forecast-for-revenue-of-human-genome-sciences/ (last visited December 31, 2024)
Estimated revenue of biotech company Human Genome Sciences from 2011 to 2014 (in billion U.S. dollars) [Graph], Der Aktionär, November 17, 2010. [Online]. Available: https://www.statista.com/statistics/270556/forecast-for-revenue-of-human-genome-sciences/